Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 9Breast 9Thoracic 4Head & Neck 4Dermatologic 4Genitourinary 3Gynecologic 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Endocrine 1CNS 1

Conditions

Uterine Cervical Neoplasms 653Ovarian Neoplasms 441Endometrial Neoplasms 290Breast Neoplasms 179Uterine Cervical Dysplasia 133Neoplasms 86Carcinoma, Ovarian Epithelial 80Papillomavirus Infections 69Prostatic Neoplasms 67Uterine Neoplasms 66Vulvar Neoplasms 64Colorectal Neoplasms 59Fallopian Tube Neoplasms 54Colonic Neoplasms 47Peritoneal Neoplasms 45Pancreatic Neoplasms 45Lung Neoplasms 45Urinary Bladder Neoplasms 39Vaginal Neoplasms 34Gynecologic Cancer 33Stomach Neoplasms 32Head and Neck Neoplasms 31Hereditary Breast and Ovarian Cancer Syndrome 27Sarcoma 26Rectal Neoplasms 26Pelvic Neoplasms 26Melanoma 25Esophageal Neoplasms 25Recurrence 24Ovarian Cysts 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Patient Satisfaction × Gynecologic × Clear all
NCT06459271 2025-12-16

Feasibility of CALM in Patients With Ovarian Cancer

University Health Network, Toronto

Phase NA Recruiting
50 enrolled
Gynecologic

Ovarian Neoplasms, Patient Satisfaction

NCT03168048 2017-05-30

OPTIMISE-1

Heidelberg University

Phase NA Unknown
50 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Pelvic Neoplasms, Personal Satisfaction, Thoracic Neoplasms, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡